Oncomatryx Biopharma

Derio, Spain · Founded 2009 · Privately Held (backing)

Developer of stroma-targeted precision drugs and diagnostics intended to fight against invasive tumours. Oncomatryx Biopharma is based in Derio, Spain and was founded in 2009. Its last reported valuation was $112 million in Mar 2022. It has raised $146 million.

Last reported valuation
$111.8M
Oct 2026
Priced at
—
Total raised
$146.0M
Last round
—
No prints on record

No secondary trades in Oncomatryx Biopharma shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Oncomatryx Biopharma with a free account
  • ·Watch Oncomatryx Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Oncomatryx Biopharma prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Oncomatryx Biopharma stock.